Litcius/Paper detail

Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets

Ana Cordeiro, Catarina Gomes, Joana Bicker, Ana Fortuna

2024Drug Discovery Today20 citationsDOIOpen Access PDF

Abstract

As the global population ages, the need to prolong lifespan and healthspan becomes increasingly imperative. Understanding the molecular determinants underlying cognitive resilience, together with changes during aging and the (epi)genetic factors that predispose an individual to decreased cognitive resilience, open avenues for researching novel therapies. This review provides a critical and timely appraisal of the molecular mechanisms underlying cognitive resilience, framed within a critical analysis of emerging therapeutic strategies to mitigate age-related cognitive decline. Significant insights from both animals and human subjects are discussed herein, directed either toward active pharmaceutical ingredients (drug repositioning or macromolecules), or, alternatively, advanced cellular therapies.

Topics & Concepts

CognitionCognitive agingResilience (materials science)Psychological resilienceCritical appraisalCognitive declinePopulationDrugMedicinePsychologyNeurosciencePharmacologyDementiaPsychotherapistAlternative medicineEnvironmental healthPathologyThermodynamicsPhysicsDiseaseNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersAlzheimer's disease research and treatments
Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets | Litcius